Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs.
about
Living bacterial sacrificial porogens to engineer decellularized porous scaffoldsNanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.Preparation and Evaluation of PLGA-Coated Capsaicin Magnetic Nanoparticles.Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair.Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles.Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.Multifunctional, JNK-inhibiting nanotherapeutics for augmented elastic matrix regenerative repair in aortic aneurysms.Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications.Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF.Effective parameters in surface cross-linking of acrylic-based water absorbent polymer particles using bisphenol A diethylene glycidyl ether and cycloaliphatic diepoxide
P2860
Q28477943-6DE869C1-3480-4F14-A012-4CE25443EBEEQ37684006-F4C461AD-108D-476E-82E0-6B834D76CF4FQ38888274-CCD3FDCC-0E35-4243-B7BA-131E956793AAQ39754185-26017F3E-4CEE-4FEC-AEC4-EA60E38ED57FQ41826178-F89C55EB-556C-488E-B45A-9B1836D95B33Q42198535-3E845CF7-8856-415B-8F8F-B5D9144FF831Q47331581-0C531058-98EB-4B53-B962-C923BB92490BQ47712218-47DBABC3-9830-4C9D-A476-EB3C9DBA205EQ48240255-60BE3A96-68CD-4E77-BD73-E48DA2B99F6EQ48405142-41B5837F-24B3-4DEA-9F3E-3C5AB3D52017Q57353518-3C21F868-B140-43FB-A5FC-42796B3749B3
P2860
Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Reduction in the initial-burst ...... rophilic or hydrophobic drugs.
@en
Reduction in the initial-burst ...... rophilic or hydrophobic drugs.
@nl
type
label
Reduction in the initial-burst ...... rophilic or hydrophobic drugs.
@en
Reduction in the initial-burst ...... rophilic or hydrophobic drugs.
@nl
prefLabel
Reduction in the initial-burst ...... rophilic or hydrophobic drugs.
@en
Reduction in the initial-burst ...... rophilic or hydrophobic drugs.
@nl
P2093
P2860
P356
P1476
Reduction in the initial-burst ...... rophilic or hydrophobic drugs.
@en
P2093
Amol J Thote
John T Chappell
Rajesh Kumar
Ram B Gupta
P2860
P356
10.1081/DDC-43985
P407
P577
2005-01-01T00:00:00Z